82 related articles for article (PubMed ID: 26454157)
1. WCRF-AICR continuous update project: Systematic literature review of prospective studies on circulating 25-hydroxyvitamin D and kidney cancer risk.
Darling AL; Abar L; Norat T
J Steroid Biochem Mol Biol; 2016 Nov; 164():85-89. PubMed ID: 26454157
[TBL] [Abstract][Full Text] [Related]
2. Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Gallicchio L; Moore LE; Stevens VL; Ahn J; Albanes D; Hartmuller V; Setiawan VW; Helzlsouer KJ; Yang G; Xiang YB; Shu XO; Snyder K; Weinstein SJ; Yu K; Zeleniuch-Jacquotte A; Zheng W; Cai Q; Campbell DS; Chen Y; Chow WH; Horst RL; Kolonel LN; McCullough ML; Purdue MP; Koenig KL
Am J Epidemiol; 2010 Jul; 172(1):47-57. PubMed ID: 20562187
[TBL] [Abstract][Full Text] [Related]
3. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL
J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801
[TBL] [Abstract][Full Text] [Related]
4. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Stolzenberg-Solomon RZ; Jacobs EJ; Arslan AA; Qi D; Patel AV; Helzlsouer KJ; Weinstein SJ; McCullough ML; Purdue MP; Shu XO; Snyder K; Virtamo J; Wilkins LR; Yu K; Zeleniuch-Jacquotte A; Zheng W; Albanes D; Cai Q; Harvey C; Hayes R; Clipp S; Horst RL; Irish L; Koenig K; Le Marchand L; Kolonel LN
Am J Epidemiol; 2010 Jul; 172(1):81-93. PubMed ID: 20562185
[TBL] [Abstract][Full Text] [Related]
5. Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Zheng W; Danforth KN; Tworoger SS; Goodman MT; Arslan AA; Patel AV; McCullough ML; Weinstein SJ; Kolonel LN; Purdue MP; Shu XO; Snyder K; Steplowski E; Visvanathan K; Yu K; Zeleniuch-Jacquotte A; Gao YT; Hankinson SE; Harvey C; Hayes RB; Henderson BE; Horst RL; Helzlsouer KJ
Am J Epidemiol; 2010 Jul; 172(1):70-80. PubMed ID: 20562186
[TBL] [Abstract][Full Text] [Related]
6. Adherence to World Cancer Research Fund/American Institute for Cancer Research recommendations and pancreatic cancer risk.
Lucas AL; Bravi F; Boffetta P; Polesel J; Serraino D; La Vecchia C; Bosetti C
Cancer Epidemiol; 2016 Feb; 40():15-21. PubMed ID: 26605429
[TBL] [Abstract][Full Text] [Related]
7. Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Travis RC; Crowe FL; Allen NE; Appleby PN; Roddam AW; Tjønneland A; Olsen A; Linseisen J; Kaaks R; Boeing H; Kröger J; Trichopoulou A; Dilis V; Trichopoulos D; Vineis P; Palli D; Tumino R; Sieri S; Bueno-de-Mesquita HB; van Duijnhoven FJ; Chirlaque MD; Barricarte A; Larrañaga N; González CA; Argüelles MV; Sánchez MJ; Stattin P; Hallmans G; Khaw KT; Bingham S; Rinaldi S; Slimani N; Jenab M; Riboli E; Key TJ
Am J Epidemiol; 2009 May; 169(10):1223-32. PubMed ID: 19359375
[TBL] [Abstract][Full Text] [Related]
8. Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Purdue MP; Freedman DM; Gapstur SM; Helzlsouer KJ; Laden F; Lim U; Maskarinec G; Rothman N; Shu XO; Stevens VL; Zeleniuch-Jacquotte A; Albanes D; Bertrand K; Weinstein SJ; Yu K; Irish L; Horst RL; Hoffman-Bolton J; Giovannucci EL; Kolonel LN; Snyder K; Willett W; Arslan AA; Hayes RB; Zheng W; Xiang YB; Hartge P
Am J Epidemiol; 2010 Jul; 172(1):58-69. PubMed ID: 20562184
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and meta-analysis of the 2007 WCRF/AICR score in relation to cancer-related health outcomes.
Solans M; Chan DSM; Mitrou P; Norat T; Romaguera D
Ann Oncol; 2020 Mar; 31(3):352-368. PubMed ID: 32067678
[TBL] [Abstract][Full Text] [Related]
10. Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and colorectal cancer risk.
Turati F; Bravi F; Di Maso M; Bosetti C; Polesel J; Serraino D; Dalmartello M; Giacosa A; Montella M; Tavani A; Negri E; La Vecchia C
Eur J Cancer; 2017 Nov; 85():86-94. PubMed ID: 28892777
[TBL] [Abstract][Full Text] [Related]
11. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Gallicchio L; Helzlsouer KJ; Chow WH; Freedman DM; Hankinson SE; Hartge P; Hartmuller V; Harvey C; Hayes RB; Horst RL; Koenig KL; Kolonel LN; Laden F; McCullough ML; Parisi D; Purdue MP; Shu XO; Snyder K; Stolzenberg-Solomon RZ; Tworoger SS; Varanasi A; Virtamo J; Wilkens LR; Xiang YB; Yu K; Zeleniuch-Jacquotte A; Zheng W; Abnet CC; Albanes D; Bertrand K; Weinstein SJ
Am J Epidemiol; 2010 Jul; 172(1):10-20. PubMed ID: 20562188
[TBL] [Abstract][Full Text] [Related]
12. Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Abnet CC; Chen Y; Chow WH; Gao YT; Helzlsouer KJ; Le Marchand L; McCullough ML; Shikany JM; Virtamo J; Weinstein SJ; Xiang YB; Yu K; Zheng W; Albanes D; Arslan AA; Campbell DS; Campbell PT; Hayes RB; Horst RL; Kolonel LN; Nomura AM; Purdue MP; Snyder K; Shu XO
Am J Epidemiol; 2010 Jul; 172(1):94-106. PubMed ID: 20562192
[TBL] [Abstract][Full Text] [Related]
13. Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis.
Garland CF; Gorham ED
J Steroid Biochem Mol Biol; 2017 Apr; 168():1-8. PubMed ID: 27993551
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
15. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk.
Touvier M; Chan DS; Lau R; Aune D; Vieira R; Greenwood DC; Kampman E; Riboli E; Hercberg S; Norat T
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1003-16. PubMed ID: 21378269
[TBL] [Abstract][Full Text] [Related]
16. Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Helzlsouer KJ;
Am J Epidemiol; 2010 Jul; 172(1):4-9. PubMed ID: 20562193
[TBL] [Abstract][Full Text] [Related]
17. Operationalizing the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Cancer Prevention Recommendations: A Standardized Scoring System.
Shams-White MM; Brockton NT; Mitrou P; Romaguera D; Brown S; Bender A; Kahle LL; Reedy J
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31336836
[TBL] [Abstract][Full Text] [Related]
18. Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations and pancreatic cancer incidence and mortality: A prospective cohort study.
Zhang ZQ; Li QJ; Hao FB; Wu YQ; Liu S; Zhong GC
Cancer Med; 2020 Sep; 9(18):6843-6853. PubMed ID: 32716590
[TBL] [Abstract][Full Text] [Related]
19. Lung Cancer Risk in Men and Compliance with the 2018 WCRF/AICR Cancer Prevention Recommendations.
Hawrysz I; Wadolowska L; Slowinska MA; Czerwinska A; Golota JJ
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36296978
[TBL] [Abstract][Full Text] [Related]
20. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
Bilinski K; Boyages J
Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
